DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 10.722
EU - Europa 6.759
AS - Asia 6.410
SA - Sud America 703
Continente sconosciuto - Info sul continente non disponibili 633
AF - Africa 89
OC - Oceania 4
Totale 25.320
Nazione #
US - Stati Uniti d'America 10.485
SG - Singapore 2.635
CN - Cina 1.748
IT - Italia 1.528
IE - Irlanda 861
UA - Ucraina 794
GB - Regno Unito 694
RU - Federazione Russa 636
SE - Svezia 625
VN - Vietnam 622
FR - Francia 553
TR - Turchia 552
BR - Brasile 546
DE - Germania 487
IN - India 312
FI - Finlandia 208
BD - Bangladesh 148
CA - Canada 117
HK - Hong Kong 115
PL - Polonia 66
MX - Messico 60
AR - Argentina 54
ES - Italia 54
BE - Belgio 51
JP - Giappone 45
AT - Austria 38
CZ - Repubblica Ceca 35
IQ - Iraq 34
NL - Olanda 32
CO - Colombia 29
KR - Corea 29
ZA - Sudafrica 26
ID - Indonesia 22
IR - Iran 22
LT - Lituania 21
EC - Ecuador 20
PK - Pakistan 17
SA - Arabia Saudita 16
JM - Giamaica 14
VE - Venezuela 14
GR - Grecia 13
KE - Kenya 13
MA - Marocco 13
UZ - Uzbekistan 12
CL - Cile 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EU - Europa 10
PE - Perù 10
TN - Tunisia 10
EG - Egitto 9
IL - Israele 9
PY - Paraguay 8
RO - Romania 8
AZ - Azerbaigian 7
CR - Costa Rica 7
MY - Malesia 7
NP - Nepal 7
AL - Albania 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
PH - Filippine 6
PT - Portogallo 6
DZ - Algeria 5
EE - Estonia 5
PA - Panama 5
GT - Guatemala 4
KZ - Kazakistan 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CG - Congo 3
ET - Etiopia 3
GY - Guiana 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
NO - Norvegia 3
UY - Uruguay 3
AM - Armenia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
NG - Nigeria 2
RS - Serbia 2
SR - Suriname 2
SV - El Salvador 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 24.680
Città #
Singapore 1.980
San Jose 1.185
Chandler 1.123
Jacksonville 931
Dublin 848
Ashburn 687
Southend 460
Dallas 451
Beijing 407
Council Bluffs 402
Princeton 373
Chieti 334
Izmir 300
Nanjing 266
Santa Clara 256
Los Angeles 236
Dearborn 228
The Dalles 206
Ho Chi Minh City 203
Ann Arbor 200
New York 189
Wilmington 175
Munich 150
Hanoi 147
Cambridge 146
Altamura 143
Tongling 118
Pescara 112
Hong Kong 99
Nanchang 95
Buffalo 94
Boardman 91
Moscow 79
Shenyang 67
São Paulo 59
Columbus 55
Tianjin 54
Woodbridge 53
Rome 52
Brussels 48
Hebei 48
Kunming 48
Redondo Beach 48
Frankfurt am Main 45
Orem 45
Washington 45
Hefei 44
Houston 44
Atlanta 43
Warsaw 43
Tokyo 42
Helsinki 39
Montreal 39
Milan 33
Chennai 32
Da Nang 32
Denver 32
Brno 31
Brooklyn 31
Jinan 30
Phoenix 30
Grevenbroich 29
Kocaeli 29
London 29
Zhengzhou 29
Dong Ket 28
San Francisco 28
Chicago 27
Toronto 27
Falls Church 26
Jiaxing 26
Seattle 26
Turku 26
Haiphong 25
Leawood 25
Mexico City 25
Nuremberg 25
Seoul 25
Vienna 23
Augusta 22
Boston 22
Poplar 22
Hangzhou 21
Guangzhou 20
Johannesburg 20
Norwalk 20
San Mateo 20
Changsha 19
Ningbo 19
Stockholm 19
Ancona 17
Manchester 17
Bologna 16
Lanciano 15
Rio de Janeiro 15
Amsterdam 14
Ardabil 14
Auburn Hills 14
Biên Hòa 14
Brasília 14
Totale 14.778
Nome #
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 461
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 243
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 219
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 205
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 204
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 194
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 188
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 184
Carvacrol codrugs: A new approach in the antimicrobial plan 184
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 176
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 175
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 175
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 172
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity 170
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 170
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 169
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 167
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 165
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 162
Synthesis of a novel TRH-related sulphonamido peptide 161
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 161
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 160
Effect of MRJF4 on C6 glioma cells proliferation and migration 160
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 159
NSAID Coniugates for the treatment of Alzheimer's Disease 159
Carvacrol prodrugs as novel antimicrobial agents 159
Advances in prodrug design for Parkinson's disease 159
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 158
Carvacrol and its derivatives as antibacterial agents 158
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 157
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 155
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 155
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 153
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 153
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 153
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 152
Antiparkinson Prodrugs 150
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 149
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 148
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 148
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 148
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 147
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 146
Synthesis and antioxidant properties of novel memantine derivatives 146
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 145
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 145
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 145
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 143
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 143
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 143
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 143
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 143
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 142
New drug delivery strategies for improved Parkinson’s disease therapy 140
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 140
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 140
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 139
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 139
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 138
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 138
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 137
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 137
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 136
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 135
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 135
Designing Prodrugs for the Treatment of Parkinson's Disease 135
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 135
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 135
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 134
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 134
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 133
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 133
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 133
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 131
Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells 131
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 131
Analytical Methods to Best Detect Fluorescent Probe Loading Nanoparticles in Biological Samples 131
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 131
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 131
L-Dopa- and dopamine- (R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties 130
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 130
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 130
Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination 129
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 128
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 128
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 127
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 127
Multiple lipid nanoparticles as antimicrobial drug delivery systems 126
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 125
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 125
Role of Dietary Supplements in the Management of Parkinson's Disease 125
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 125
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 124
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 124
Drug Delivery Strategies for Alzheimer's Disease Treatment 124
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 124
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle 123
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 123
From self-Assembly to healing: Engineering ultra-Small peptides into supramolecular hydrogels for controlled drug release 122
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 122
Totale 15.082
Categoria #
all - tutte 104.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022853 0 0 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20253.806 192 720 616 122 50 225 100 199 312 170 472 628
2025/20267.887 684 363 737 909 693 462 1.382 489 773 652 487 256
2026/20271.108 553 420 135 0 0 0 0 0 0 0 0 0
Totale 25.320